ARCHIVES

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

NCI Proposes New Grants and Centers For Molecular Target-Based Therapeutics

March 26, 1999

NCI Still Supporting Construction Grants Despite Big Cuts

February 20, 1981

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

DCT Board Okays Concepts Of Four New Grant Projects, Four Competitive Contract Delays Chlordane Study

March 9, 1984

NRC Undertake Diet, Nutrition And Cancer , Plans Meeting Nov. 6

September 26, 1980